Gaviscon is a non-prescription medication for the treatment of
heartburnand GERD (acid reflux). It is produced and distributed in the UK by Reckitt Benckiserand by GlaxoSmithKlinein the US and Canada.
Gaviscon is taken to treat heartburn, similar to other
antacids. Gaviscon is based on a mixture of the buffering agents and neutralizers calcium carbonateand sodium bicarbonate, the laxative magnesium carbonateand the gelling agents alginic acidand aluminium hydroxide. When taken by mouth the combination of the alginic acid and bicarbonate creates a barrier which prevents stomach acid from refluxing back up into the esophagus.
It may be helpful to combine treatment with lifestyle modifications such as loss of weight, raising the head of the bed at night, reduction in alcohol consumption and cessation of smoking [Kumar & Clark: Clinical Medicine 6e p.276 Elsevier 2005] .
The Gaviscon infant variant for infants (≥ 1 years) and young children contains only the
gelling agents sodium alginateand magnesium alginate. It is used to help stabilize the stomach contents and reduce reflux and regurgitation, but is not an antacid.
* [http://www.gaviscon.co.uk/ Official "Gaviscon UK" website]
* [http://www.heartburnexpert.co.uk/ "Gaviscon UK" Advice website]
* [http://www.gaviscon.com Official "Gaviscon US" website]
* [http://www.gaviscon.ca Official "Gaviscon Canada" website]
Wikimedia Foundation. 2010.